|
Welcome, New SoCalBio Members
| |
|
Join SoCalBio
Join SoCalBio leaders to promote the biotech and device industries in Los Angeles, Orange County and neighboring communities for job creation and overall economic growth.
|  |
| Thanks to SoCalBio Media Partners
|
|
|
|
March 5, 2012
|  Editor: Ahmed Enany
President & CEO
Southern California
Biomedical Council
enany@socalbio.org
www.socalbio.org
|
| New Members | CellWorks of Irvine Joins SoCalBio
 Cellworks is a private, venture-backed biopharmaceutical therapeutic design and development company based on platform predicting clinical outcomes. The Cellworks designed innovative best-in-class therapies are substantially derisked with dramatically increased probability of success. The company's lead compound for the treatment of Rheumatoid Arthritis is ready for clinical development. CellWorks will be represented in SoCalBio by its President & CEO Taher Abbasi (photo right).. Learn more |
| Coming in April | 2012 SoCalBio Workforce Summit
Aligning Training & Workforce Development with Company Performance Metrics Click on banner to see agenda |
| Coming in September | |
|
| Acquisition | NantWorks Acquires Boston Life Labs
 NantWorks, the West Los Angeles company founded by biotech billionaire Dr. Patrick Soon-Shiong (photo right), said the technology developed by Boston Life Labs of Phoenix will be integrated with other recent acquisitions in the health information sphere. Boston Life Labs, which has been renamed NantCare LLC, makes hardware and software products enabling wireless devices to measure blood pressure, blood sugar, weight and medication management and transmit the information to a patient's doctor ... Read more at the LABJ |
 | |
Click on image for more info
|
|
| Recent Financing | C3 Jian Raises $30 Million
 All three current primary shareholders of C3 Jian, Wyssta Investments, Inc., Renaissance Health Services Corp., and Corvesta, Inc., participated in the financing of C3 Jian. Founded by UCLA scientist Dr. Wenyen Shi (photo right), C3 Jian expects to use the proceeds to advance its lead product, C16G2, a peptide drug targeting dental caries, into human clinical trials in the United States. The Company is planning to file an Investigational New Drug Application (IND) with the U.S. Food and Drug Administration in April. Proceeds from the financing will also be used to support production development and scale-up, GMP manufacturing, as well as final development and clinical testing of a hand held diagnostic product related to C16G2 ... Read press release
|
| Recent IPOs | Ceres IPO Brings in $65M
Ceres, an energy crop company, priced its initial public offering on February 22 to become the first agricultural biotechnology company to go public on a U.S. exchange since Monsanto in 2000. Ceres raised $65 million through the offering, far less than the $110 million it sought to raise... Read more |
| SoCalBio Sponsored | | |
| 
SoCalBio members receive $200 discount per person on admission to the BioPharm America 2012. Click here to RSVP |
| RNAi Collaboration | Arrowhead Research Corporation and Axolabs GmbH Enter into Strategic Alliance and Master Services Agreement for RNAi Therapeutics
 Under the terms of the agreement, Axolabs, founded by the principals of former Roche Center of Excellence for RNAi Therapeutics in Kulmbach, Germany, will provide Arrowhead and its partners first-in-class oligonucleotide optimization, synthesis, and analytics. These services include bioinformatics for siRNA design; lead identification, optimization and characterization; as well as siRNA synthesis and CMC-related activities. "With multiple candidates in the clinic addressing a wide range of indications, data demonstrating the power of RNAi as a therapeutic modality are rapidly accumulating," said Dr. Christopher Anzalone, Arrowhead's CEO (photo right) ... Read press release |
| People on the Move | Ex Amgen Brian Varnum Appointed by C3 Jian as Vice President for Product Development
C3 Jian, Inc., a private company focused on providing improved oral healthcare, announced that ex-Amgen executive Brian C. Varnum, Ph.D., has been appointed Vice President of Product Development. Dr. Varnum will be responsible for the commercial development of the Company's lead products, with particular focus on C3 Jian's C16G2, a therapeutic peptide targeting dental caries ... Read press release
|
Jobs Available
| Childrens Hospital Los Angeles
Alliance Medical Products (Irvine)
Click here to apply
- Aseptic Fill Technicians (3-5 years aseptic experience minimum)
- Production Operators (Aseptic filling of drug products, 3 years experience)
- Sr. Process Engineers (Must come from aseptic filling facility,prefer automated filling/packaging/setup and validation experience, BSME (or equiv) 5-10 years experience)
- Maintenance Mechanics (hands on ability to conduct routine preventive maintenance on production and laboratory equipment)
Physician Therapeutics (Los Angeles)
|
|
| About SoCalBio |
 SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio |
|
|
March 30, 4:00 - 7:00 pm at Baxter Bioscience in Westlake Village: 